Lung ultrasound monitoring in patients with COVID-19 on home isolation

Many patients with COVID-19, the clinical illness caused by SARS-CoV-2 infection, exhibit mild symptoms and do not require hospitalization. Instead, these patients are often referred for 14-days of home isolation as symptoms resolve. Lung ultrasound is well-established as an important means of evalu...

Full description

Saved in:
Bibliographic Details
Published inThe American journal of emergency medicine Vol. 38; no. 12; pp. 2759.e5 - 2759.e8
Main Authors Shokoohi, Hamid, Duggan, Nicole M., García-de-Casasola Sánchez, Gonzalo, Torres-Arrese, Marta, Tung-Chen, Yale
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.12.2020
Elsevier Limited
Published by Elsevier Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Many patients with COVID-19, the clinical illness caused by SARS-CoV-2 infection, exhibit mild symptoms and do not require hospitalization. Instead, these patients are often referred for 14-days of home isolation as symptoms resolve. Lung ultrasound is well-established as an important means of evaluating lung pathology in patients in the emergency department and in intensive care units. Ultrasound is also being used to assess admitted patients with COVID-19. However, data on the progression of sonographic findings in patients with COVID-19 on home isolation is lacking. Here we present a case series of a group of physician patients with COVID-19 who monitored themselves daily while in home isolation using lung point-of-care ultrasound (POCUS). Lung POCUS findings corresponded with symptom onset and resolution in all 3 patients with confirmed COVID-19 during the 14-day isolation period. Lung POCUS may offer a feasible means of monitoring patients with COVID-19 who are on home isolation. Further studies correlating sonographic findings to disease progression and prognosis will be valuable.
ISSN:0735-6757
1532-8171
DOI:10.1016/j.ajem.2020.05.079